Evidence map›Paper›PMID 30417133›Full record

ArticleBiochemistry and biophysics reports2018

The calcium sensitizer drug MCI-154 binds the structural C-terminal domain of cardiac troponin C.

Monica X Li, Shorena Gelozia, Gaddafi I Danmaliki, Yurong Wen, Philip B Liu, M Joanne Lemieux, Frederick G West, Brian D Sykes, Peter M Hwang

Open access · goldAbstract read
In one paragraph

Article in Biochemistry and biophysics reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 2 countries.

Monica X LiDepartment of Medicine, University of Alberta, Edmonton, Alberta, Canada T6G 2R3.
Shorena GeloziaDepartment of Chemistry, University of Alberta, Edmonton, Alberta, Canada T6G 2G2.
Gaddafi I DanmalikiDepartment of Biochemistry, University of Alberta, Edmonton, Alberta, Canada T6G 2H7.
Yurong WenDepartment of Biochemistry, University of Alberta, Edmonton, Alberta, Canada T6G 2H7.
Philip B LiuDepartment of Medicine, University of Alberta, Edmonton, Alberta, Canada T6G 2R3.
M Joanne LemieuxDepartment of Biochemistry, University of Alberta, Edmonton, Alberta, Canada T6G 2H7.
Frederick G WestDepartment of Chemistry, University of Alberta, Edmonton, Alberta, Canada T6G 2G2.
Brian D SykesDepartment of Biochemistry, University of Alberta, Edmonton, Alberta, Canada T6G 2H7.
Peter M HwangDepartment of Medicine, University of Alberta, Edmonton, Alberta, Canada T6G 2R3.
University of Alberta · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The compound MCI-154 was previously shown to increase the calcium sensitivity of cardiac muscle contraction. Using solution NMR spectroscopy, we demonstrate that MCI-154 interacts with the calcium-sensing subunit of the cardiac troponin complex, cardiac troponin C (cTnC). Surprisingly, however, it binds only to the structural C-terminal domain of cTnC (cCTnC), and not to the regulatory N-terminal domain (cNTnC) that determines the calcium sensitivity of cardiac muscle. Physiologically, cTnC is always bound to cardiac troponin I (cTnI), so we examined its interaction with MCI-154 in the presence of two soluble constructs, cTnI

Indexed as

Calcium sensitizerDrug bindingProtein-protein interactionSolution NMR spectroscopy

Identifiers

PMID30417133
PMCPMC6218639
OpenAlexW2899048634

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.